Literature DB >> 2016541

Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.

A B Lang1, U Bruderer, G Senyk, T L Pitt, J W Larrick, S J Cryz.   

Abstract

We report the generation and the characterization of a set of human monoclonal antibodies (HmAb) specific for Gram-negative bacteria of Klebsiella pneumoniae. The eight human hybridomas secrete either IgM kappa, IgA1 kappa, or IgA2 kappa antibodies. One HmAb binds bacteria of only one serotype. Five HmAb recognize non-overlapping clusters of 2, 3, or 10 different serotypes. The remaining two HmAb both recognize three serotypes. Two serotypes are recognized by both HmAb, and in addition both HmAb bind one more nonidentical serotype. These results suggest that in man, epitopes are immunodominant, different from serotype-specific determinants detected by conventional rabbit antisera. Screening of clinical isolates revealed that the HmAb recognize not only representative typing strains but also most isolates of the corresponding serotype. In addition, most of the isolates that were non-typable by polyclonal antisera were recognized by one of the HmAb. Fine specificity analyses revealed that all HmAb are highly specific for the isolated capsular polysaccharides (CPS) of bacteria within the corresponding cluster of serotypes. However, the avidity of a HmAb for the different CPS can differ significantly. Taken together, our results suggest that the unequivocal interactions between HmAb and CPS offer the basis for an alternative, better defined classification system, and that passive immunization with a limited number of HmAb may provide a feasible strategy for the protection against the majority of fatal, nosocomial infections with multidrug-resistant strains of K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016541

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Scale-up and optimization of culture conditions of a human heterohybridoma producing serotype-specific antibodies to Pseudomonas aeruginosa.

Authors:  U Schürch; S J Cryz; A B Lang
Journal:  Appl Microbiol Biotechnol       Date:  1992-07       Impact factor: 4.813

2.  Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits.

Authors:  Elizabeth Diago-Navarro; Liang Chen; Virginie Passet; Seth Burack; Amaia Ulacia-Hernando; Rosy Priya Kodiyanplakkal; Michael H Levi; Sylvain Brisse; Barry N Kreiswirth; Bettina C Fries
Journal:  J Infect Dis       Date:  2014-03-14       Impact factor: 5.226

3.  Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia.

Authors:  T K Held; M Trautmann; M E Mielke; H Neudeck; S J Cryz; A S Cross
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Characterization of the Shigella serotype D (S. sonnei) O polysaccharide and the enterobacterial R1 lipopolysaccharide core by use of mouse monoclonal antibodies.

Authors:  J F Viret; U Bruderer; A B Lang
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.

Authors:  T Rukavina; B Tícac; M Susa; N Jendrike; S Jonjíc; P Lucin; R Marre; M Doríc; M Trautmann
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus.

Authors:  J E Crowe; P Y Cheung; E F Wallace; R M Chanock; J W Larrick; B R Murphy; K Fry
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

7.  A murine monoclonal antibody defines a unique epitope shared by Klebsiella lipopolysaccharides.

Authors:  M Trautmann; K Vogt; C Hammack; A S Cross
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

8.  Proinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infections.

Authors:  Tomislav Rukavina; Vanja Vasiljev; Brigita Ticac
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

9.  A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World.

Authors:  Michael P Motley; Bettina C Fries
Journal:  mSphere       Date:  2017-10-04       Impact factor: 4.389

Review 10.  The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections.

Authors:  Marco Cavaco; Miguel A R B Castanho; Vera Neves
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.